Skip to main content
. 2011 Aug 8;589(Pt 19):4671–4679. doi: 10.1113/jphysiol.2011.216218

Figure 2. Percentage of the maximal concentration of cutaneous vascular conductance (% SkBF max) as a function of the log concentration of the ET-A receptor antagonist (BQ-123) and the ET-B receptor antagonist (BQ-788) in women with (PCOS) and without (Control) polycystic ovary syndrome.

Figure 2

Data are presented as means ± SEM.